Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Tracon Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 42 | 44 | +2 |
| Shares | 9.19M | 9.02M | −176.0K (−1.9%) |
| Value | $72.8M | $58.5M | −$14.3M (−19.6%) |
New holders (7)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 72,954 | $473.0K | 0.00% |
| Dimensional Fund Advisors LP | 57,335 | $372.0K | 0.00% |
| Telemetry Investments, L.L.C. | 40,000 | $260.0K | 0.36% |
| ACT Capital Management, LLC | 28,500 | $185.0K | 0.10% |
| Northern Trust Corp | 17,337 | $113.0K | 0.00% |
| Advisory Services Network, LLC | 1,000 | $6.00K | 0.00% |
| Bank of America Corp | 140 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Ameriprise Financial Inc | 88,484 | $728.0K |
| Millennium Management LLC | 51,794 | $426.0K |
| Susquehanna International Group, LLP | 12,586 | $104.0K |
| Total Clarity Wealth Management, Inc. | 6,825 | $56.0K |
| Tower Research Capital LLC (TRC) | 5,486 | $45.0K |